New mRNA vaccine strategy dramatically amplifies cancer-fighting T cells
Engineers from the University of Houston, MIT and Harvard have developed a new mRNA-based strategy that dramatically amplifies the T-cell response to vaccines - an advance that could lead to far more powerful cancer...
German start-up receives funding for smart epilepsy wearables
Smart Monitoring for People with Epilepsy Start-up project at the University Hospital Bonn and University of Bonn to receive €2.7 million in GO-Bio next funding from the BMFTR. The PearNet project is developing special...
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational...
Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, today announced it has received Health Research Authority (HRA) and Research Ethics Committee (REC) approval for its 500-patient clinical observational study, PEMP (Predicting...
Codon Optimization Isn’t Equal: Benchmarking Gene Design for Antibody Expression
Register Now
Justin Byers Founder and CEOAxio BioPharma View Bio
Panelist ...
Hydrogel breakthrough offers significant advance in type 1 diabetes treatment
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing cells once transplanted...
New CRISPR breakthrough promises more affordable disease diagnostics
A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics and treatments safer, more precise, and more affordable, while opening the door to...
ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative
BOSTON — In a potentially significant advance for the genome editing field, researchers from the biotechnology company Caszyme and the Vilnius University Institute of Biotechnology in Lithuania have developed a potent and compact variant...
ASGCT 2026: Rare Instance of AAV Integration into Human Genome Linked to Brain Tumor
Rebecca Ahrens-Niklas, MD, PhD
BOSTON — A team at Children’s Hospital of Philadelphia (CHOP) led by Rebecca Ahrens-Niklas, MD, PhD, and Lindsey George, MD, has described a case of a brain tumor linked to a...
Implantable Living Materials Contain Infection-Sensing Bacteria That Release Therapeutics
Overcoming a major hurdle in the use of microbes as medicine, researchers at Harvard’s Wyss Institute and John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed an “implantable living materials” (ILMs)...
Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic...
Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, and Mediar Therapeutics (Mediar), a clinical-stage biotechnology company advancing first-in-class therapies...
